Gravar-mail: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral Type I Collagen Treatment in Patients With Diffuse Cutaneous Systemic Sclerosis: I. Oral Type I Collagen Does Not Improve Skin in All Patients, but May Improve Skin in Late-Phase Disease